The Royal Marsden Cancer Charity

We’re proud to be supporting the International Centre for Recurrent Head and Neck Cancer (IReC) – the world’s first centre dedicated to this vital area of research and treatment. Thanks to our supporters, IReC is helping to transform care for patients through pioneering research, surgical innovation and specialist training. Read more about The Royal Marsden's work and IReC’s impact below.

We are incredibly proud to be supporting the International Centre for Recurrent Head and Neck cancer (IReC). The innovative work of the EVEREST-HN programme is ambitious, and we're eager to see the development made by 2028.

We are proud to be supporting The Royal Marsden with the Quality of Services grant of £1.6 million in 2025/26 to help to provide exceptional, personalised treatment and care for patients before, during and after cancer treatment. Swipe through to see what you’ve helped us support in 2025/26. Read more: https://bit.ly/4516BAW

In 2021, Tracy was diagnosed with stage 4 bowel cancer. After 5 weeks of radiotherapy, and 19 months of chemotherapy, Tracy underwent an extensive and life-changing surgery at The Royal Marsden. Now, 2 years later, Tracy is very well and is currently cancer free. "I think we, as a family, will fundraise for The Royal Marsden Cancer Charity forever. The Royal Marsden saved my husband's life. They saved my life. And I'll be grateful forever that I've got this wonderful life back." 💬 From funding state-of-the-art equipment and groundbreaking research, to creating the very best patient environments, we will never stop looking for ways to improve the lives of people affected by cancer 💜

You heard it here first! 🚨 We’re hiring for an Individual Giving Senior Executive to join our team and take the lead on recruiting new supporters, delivering our Supporter Acquisition programme, and growing our supporter base. Sound like something you’d be interested in? 👀 Swipe across to find out more, and to get your application in ASAP, head here: https://lnkd.in/eXcmyyJG

It's been two years since the opening of the Oak Cancer Centre, and it’s amazing to see how much progress has been made. ✨   This year, thanks to your support, tens of thousands of cancer patients have received vital care, while hundreds of dedicated researchers have made advances that are already improving lives and hold the potential to benefit patients around the world. The teams within the Oak Cancer Centre have expanded their research portfolio, strengthened interdisciplinary collaborations across teams, and established pharmaceutical partnerships that will push the boundaries of cancer treatment and care. From pioneering new treatment approaches to improving patient experiences, the work taking place within The Royal Marsden NHS Foundation Trust Oak Cancer Centre is already making a huge difference to the lives of those affected by cancer. We cannot thank you enough for helping to make the Oak Cancer Centre a reality, and we can’t wait to see what the next year brings 💜 

Together, The Royal Marsden and The Royal Marsden Cancer Charity want to say a heartfelt thank you to all our incredible supporters. Whether you've donated, fundraised, volunteered, or shared our work - you've played a vital role in helping us provide the very best care to cancer patients, support life-saving research, and invest in innovative treatments. Your generosity doesn’t just make a difference here, the impact is felt around the world. The research you help fund is used by clinicians and researchers across the globe, improving the lives of cancer patients everywhere. Because of you, The Royal Marsden NHS Foundation Trust can continue to lead in cancer treatment, care and research - today, tomorrow and always. We couldn’t do it without incredible supporters you. Thank you. 💜 

Just 15 years ago, 1 in 20 patients with advanced melanoma wouldn’t survive for five years. The Checkmate 067 trial, led by The Royal Marsden NHS Foundation Trust, has shown 52% of advanced melanoma patients treated with combination immunotherapy treatments survive for at least 10 years. The trial combines immunotherapy drugs Ipilimumab and nivolumab – known to prolong lives but proven to be more effective when working together. “By giving these drugs together... the immune system is able to recognise tumours it wasn't previously recognising, react to that and destroy them.” 💬 Professor James Larkin, Consultant Medical Oncologist, presented the results of the Checkmate 067 trial Lucy, stage 4 melanoma patient, joined this trial after being told she had months to live. Three months into her treatment, her scans showed that she was doing much better. Immunotherapy treatment at The Royal Marsden is supported by The Royal Marsden Cancer Charity. Your support means that we can help patients have more time with their loved ones. Read more about this ground-breaking trial: https://bit.ly/40uBdZY

Lovely to see HRH The Princess of Wales planting 50 Catherine's Rose plants today, celebrating the incredible healing power of nature. In May this year, the Royal Horticultural Society named Catherine's Rose, bred by Harkness Roses Wholesale, after Her Royal Highness, The Princess of Wales. The beautiful coral-pink rose highlights the important role that spending time outdoors plays in bringing us joy and supporting our mental and physical wellbeing. Funds from the sales of Catherine’s Rose will go towards The Royal Marsden Cancer Charity to help The Royal Marsden NHS Foundation Trust establish a unique training programme for clinical teams across the country in prehabilitation and rehabilitation techniques that will make a huge difference to patient care. You can read more about the rose here: https://bit.ly/44uKhza